1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
VCID-UMD 2026 Grant Program is sponsored by Brain Canada Foundation and Alzheimer's Association. This program aims to fund concerted and collaborative efforts to advance the understanding of Alzheimer's Disease and Related Dementias (ADRD), with a focus on Vascular Contributions to Cognitive Impairment and Dementia (VCID) and Understanding Multiple Etiology Dementias (UMD).
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Individual research grant, with funding administered through the recipient's institution. Multidisciplinary team approaches are welcome. Brain Canada Foundation is pleased to consider partnership for successful Canadian-led applications. Confirm the full requirements in the official notice before applying.
VCID-UMD 2026 Grant Program is funded by Brain Canada Foundation and Alzheimer's Association. Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
International Research Grant Program (IRGP) is sponsored by Brain Canada Foundation and Alzheimer's Association. This program funds research that will advance the understanding of Alzheimer's disease, identify new treatment strategies, improve care for people with dementia, and further knowledge of brain health and disease prevention. Brain Canada Foundation is pleased to consider partnership for successful Canadian-led applications.
International Research Grant Program (IRGP) 2026 is sponsored by Brain Canada Foundation and Alzheimer's Association. This program funds research that will advance the understanding of Alzheimer's disease, identify new treatment strategies, improve care for people with dementia, and further knowledge of brain health and disease prevention. Brain Canada Foundation is pleased to consider partnership for successful Canadian-led applications.
ARPA-H's HEARING program (ARPA-H-SOL-26-154) — Hearing Enhancement through ARtificially Intelligent NeurotechnoloGy — held its Proposers' Day on June 8, 2026 and set Solution Summary deadlines for June 29 with Full Proposals due August 14. Single prime awardee, multiple Other Transaction Agreements, three integrated technical areas spanning intracortical recording and stimulation devices, wearable dynamic sound modulators, and AI-based auditory read/write algorithms. The first phase runs 18 months; the full effort runs 4.5 years through first-in-human clinical studies. For neurotech teams that have spent a decade in cochlear-implant or visual-prosthesis space, this is the moment the federal government bet on auditory cortex over the cochlea.
Read articleA Nature poll finds three-quarters of American scientists are considering working abroad. ERC applications from U.S. researchers have tripled. France and the EU pledged €500 million to recruit them. Inside the brain drain reshaping global science — and what it means for grant strategy.
Read articleThe National Institute on Aging's FY 2026 AD/ADRD portfolio consolidates the dementia research infrastructure layer — NCRAD, NACC, the new AI and Technology Collaboratory Coordinating Center — into a small number of large, often single-source cooperative agreements. The $113M new-research increment goes elsewhere. For investigators submitting in FY 2026, the structural change matters more than the headline dollar number.
Read article